Sangamo Therapeutics, INC

GLOBAL GENOMIC MEDICINE COMPANY

Based in CA

🤖

AI Overview

With $174K in lobbying spend across 8 quarterly filings, Sangamo Therapeutics, INC is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2020 to 2022.

$174K
Total Spend
3
Years Active
1
Firms Hired
3
Lobbyists Deployed
3
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2020$0
2021$114K
2022$60K

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Pharmacy, MED

  • Advancing Access to Precision Medicine Act (not introduced) H.R. 1730/S. 670, STAT Act Cures 2.0 (not introduced) PDUFA VII Reauthorization
  • Advancing Access to Precision Medicine Act (not introduced)
  • H.R. 1730/S. 670, Speeding Therapy Access Today (STAT) Act
  • Cures 2.0 (not introduced)
  • PDUFA VII Reauthorization

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.